Kryger Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-384,834
Closed -$7.18M 252
2022
Q1
$7.18M Buy
+384,834
New +$6.92M 0.41% 50

Other funds holding OCDX

Kryger Capital's OCDX Position: Q2 2022 in Review

Kryger Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 384,834 shares — an estimated $7.18M sold.

Kryger Capital first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $7.18M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Kryger Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Kryger Capital sold 384,834 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $7.18M.
  • Kryger Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Kryger Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $7.18M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Kryger Capital's 13F filing for Q2 2022, filed 15 Aug 2022.